• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Vfend (voriconazole) for Oral Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- March 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.

Summary View


Sections Modified Summary of Changes to Contraindications and Warnings



  • Drug Interactions
    • Table 11: Effect of Other Drugs on Voriconazole Pharmacokinetics
      • St. John's Wort
  • Monitoring of Pancreatic Function
  • Pediatric Use
    • There have been postmarketing reports of pancreatitis in pediatric patients


  • Who should not take Vfend?
    • St. John's Wort (herbal supplement)


Coadministration of Vfend with St. John's Wort is contraindicated...